fashion -WSS

fashion

author：leisure time 2025-09-06 03:53:37 - browse：39

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Former New York Mayor de Blasio and wife announce separation, but not divorce

WSS

Pope Francis asks Church to identify 21st

Princess Kate attends Wimbledon with Roger Federer: See the photos

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

STAT Readout Newsletter: Biotech news today

STAT Summit: How researchers deal with rejection

STAT Readout: Friday, Oct. 20 biotech updates

focus

fashion

hotspot

The high cost of giving birth even with insurance

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Results on Novartis prostate cancer therapy could expand its use

Novavax promises a turnaround & Lilly roils the obesity market

Israel withdraws forces after 2

Alkermes shareholders re

Is there really a nursing shortage in the U.S.?

Wildfire smoke exposes gaps in outdoor worker protections

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

focus

Questions loom on AstraZeneca cancer drug as safety concerns ebb

5 shark bites reported on Long Island as officials deploy surveillance drones

CZI to create biohub to build anti

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Wikipedia

hotspot

Wikipedia

leisure time